Software products in the medical device world, particularly those using Artificial Intelligence, do not always fit well in the current regulatory scheme. In this presentation to the IMDRF management committee in Brussels, Melissa discusses her views on how change management should be considered for these types of innovative products moving forward. As products continue to evolve, so too should the regulatory framework supporting them.